West Pharma (WST) Reports Q3 EPS of $0.44
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $362.31 -1.17%
Revenue Growth %: +2.6%
Financial Fact:
Research and development: 9M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +2.6%
Financial Fact:
Research and development: 9M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q3 EPS of $0.44, versus $0.44 reported last year. Revenue for the quarter came in at $344.5 million, versus $355.9 million reported last year.
West Pharma sees FY2015 EPS of $1.79-$1.84.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
